Search Results

10 results for public health genomics

Genomics and Population Health Action: Join the Collaboration

a crowd forming two puzzle pieces coming togehter with DNA on the ground

In February 2017, I attended a one-day meeting of leaders of the Genomics and Population Health Action Collaborative (GPHAC). This group of more than 40 organizations and individuals is dedicated to the integration of genomics into clinical and public health programs to save lives and prevent disease. (Details on GPHAC and its membership can be

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and PreventionTags

Your Genes, Your Health: The Importance of Genetic Literacy and Education

a group of people from kinder garden to health professionals standing behind a table of building blocks made out of ATCG and the word GENES and DNA

In March 2017, the National Human Genome Research Institute, in collaboration with the Foundation for the NIH and several private sector organizations, held an important strategic planning meeting in Bethesda, the Genetic Literacy, Education and Empowerment (GLEE) Initiative.  Advances in genomics over the past two decades are leading to opportunities to use genomic information in

Posted on by Muin J. Khoury MD, PhD, Katherine Kolor, PHD, Office of Public Health Genomics, Centers for Disease Control and PreventionTags , ,

The need for a next-generation public health response to rare diseases.

a crowd of people in grey and one individual standing out in color and double helices on the border of the image

In recognition of Rare Disease Day 2017, we republish, with permission, a modified extract from our recent commentary in Genetics in Medicine. Few public health research activities trigger stronger calls to public health action than research into the burden of disease. This research uses standard measures to quantify actual or potential losses that populations may

Posted on by Rodolfo Valdez (guest blogger), Scott D. Grosse (guest blogger), National Center on Birth Defects and Developmental Disabilities & Muin J. Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention4 CommentsTags

Can we use genetic screening of healthy populations to save lives and prevent disease? Join the conversation.

a doctor looking into a crystal ball filled with people - he is surrounded by a babies feet with bloodspots and a crowd of people and a stop sign with cancer on it and a stethoscope listening to a heart

On January 30, 2017, CDC held a special workshop to discuss the role of public health in the implementation of genetic screening programs beyond the newborn period. The workshop brought together panelists from the worlds of medical genetics and public health practice, including cancer, birth defects, and laboratory science. Workshop presenters and a CDC panel discussed

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention6 CommentsTags ,

2016: The Year of Precision Public Health!

2016 with DNA on the 0 and a bunch of people

In our 2015 end-of-year blog post entitled: “Public health genomics 2015: Looking back, looking ahead”, we predicted that 2016 will feature a more in-depth exploration of “key concepts for the development of precision public health beyond genomics to include a variety of personal and environmental data for preventing disease and promoting health.” One year later,

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention1 CommentTags

Happy Thanksgiving: Collect & Act on Your Family Health History

a multigenerational family eating a Thanksgiving meal with DNA

As you celebrate Thanksgiving with your family this November, remember that this special day is also National Family Health History Day. Family health history is important to your health and can help you detect unique disease risks and manage them before becoming sick, or find the right diagnosis and treatments when you have a certain

Posted on by Bob Wildin MD, Guest Blogger, Genomic Healthcare Branch, National Human Genome Research Institute and Muin J. Khoury MD, PhD, Office of Public Health Genomics, Centers for Disease Control and PreventionTags

What Gets Measured Gets Done: Public Health Progress in Familial Hypercholesterolemia

a heart with a graph and people in the foreground

Just 4 years ago, one of us (MJK) co-chaired the Familial Hypercholesterolemia (FH) Foundation’s first FH Global Summit: Awareness to Action held in Annapolis, Maryland. The Summit brought together people from academia, government, the private sector, clinicians, as well as patients with the ambitious goals of raising awareness of FH, identifying key knowledge gaps, and

Posted on by Joshua Knowles MD, guest blogger, Stanford University School of Medicine and Muin J. Khoury MD, PhD, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia1 CommentTags

Precision Public Health: More Precision Ahead for Individual and Population Interventions

people holding a sign reading Medicine & Public Health with DNA

In August 2016, we published a point-counterpoint viewpoint asking a crucial question that has been on the minds of researchers, health care providers and the public health community: “will precision medicine improve population health?” We understood that we were tackling “the elephant in the room” and hoped for reactions to this viewpoint. We were pleased

Posted on by Muin J. Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, and Sandro Galea, Dean, School of Public Health, Boston University, Boston, Massachusetts2 CommentsTags ,

Precision Medicine and Population Health: Dealing With the Elephant in the Room

a elephant in a room with a crowd on one side and doctors on the other side including DNA above on the wall

In this week’s Journal of American Medical Association, we published a point-counterpoint commentary on the impact of precision medicine on population health. Announcement of the news of the US precision medicine initiative has been met with a range of responses from enthusiasm to skepticism about potential benefits, limitations and return on investment. In considering the

Posted on by Muin J. Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, and Sandro Galea, Dean, School of Public Health, Boston University, Boston, Massachusetts2 CommentsTags

From Genes to Public Health 1996-2016: The Train Has Left the Station

train leaving the station with DNA

In 1996, a working group from the Centers for Disease Control and Prevention published an article in the American Journal of Public Health entitled: “From Genes to Public Health: Applications of Genetic Technology in Disease Prevention.” The agency-wide group assessed the implications of the Human Genome Project and related technologies for public health and disease

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and PreventionTags